Because the intestinal tract is regionally heterogenous, traditional sampling methods such as endoscopic biopsies and stool collection offer limited utility in understanding how intestinal gut microbes and metabolites impact human physiology. Increasingly, research shows that the gut microbiome and metabolome play a critical role in numerous diseases as well as in food digestion, immune system regulation, and protection against pathogens, all of which have implications for human health and disease. Findings from the landmark study suggest that CapScan, the first and only device of its kind, has the potential to accelerate microbiome-related research and biopharmaceutical drug-discovery and development programs.

SAN FRANCISCO-( BUSINESS WIRE)-Envivo Bio, a biotech company advancing the gut microbiome and metabolome field, announced that new data published in Nature show the company’s proprietary CapScan® intestinal sampling device can non-invasively and accurately profile the human gut microbiome and metabolome under physiological conditions for the first time.

G2g humankind download